Virax Biolabs Group Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 878.80 K | $193.25 K | 100.00% | 8.84% |
| JUMP FINANCIAL, LLC | 05/14/2026 | 40.72 K | $8.96 K | 100.00% | 0.41% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 20 | $4 | 0.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Virax Biolabs Group Ltd institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Virax Biolabs Group Ltd. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 878,803
Jump Financial, LLC: 40,724
ADVISOR GROUP HOLDINGS, INC.: 20
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO: 0
XTX Topco Ltd: 0
NATIONAL BANK OF CANADA /FI/: 0
9.25% of Virax Biolabs Group Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 919.55 K shares in the last 24 months. This purchase volume represents approximately $183.91 K in transactions.